Clinical Trials
3 trialsNCT04622462 2024-11-07
Early Prediction of Oral Cancer by S100A7 Immunohistochemistry Signature-based Assessment
Proteocyte Diagnostics Inc.
Recruiting
NCT05853783 2024-11-07
Evaluation of Oral Potentially Malignant Disorders (OPMDs) with STRATICYTEâ„¢
Proteocyte Diagnostics Inc.
Recruiting
NCT03939364 2021-10-19
This Study is to Evaluate the Safety and Pharmacokinetics of SBS-101 in Patients With Oral Premalignant Lesions
Skyline Biosciences
Phase 1 Withdrawn